RL-007

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRL-007
Drug Alias NameRL-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor modulators
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsSchizophreniaCognition DisordersSpondylitis, Ankylosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[4
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRecognify Life Sciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophreniaCognition DisordersSpondylitis, Ankylosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A